-
Something wrong with this record ?
Epidemiological analyses to inform stroke clinical practice guidelines development
R. Líčeník, J. Klugarová, A. Pokorná, M. Bezděková, J. Jarkovský, P. Búřilová, T. Nečas, J. Mužík, S. Šebestová, D. Dolanová, M. Hunčovský, L. Dušek, M. Klugar,
Language English Country Australia
Document type Journal Article
- MeSH
- Anticoagulants administration & dosage MeSH
- Stroke diagnostic imaging epidemiology etiology therapy MeSH
- Incidence MeSH
- Platelet Aggregation Inhibitors administration & dosage MeSH
- Brain Ischemia diagnostic imaging epidemiology etiology therapy MeSH
- Humans MeSH
- Magnetic Resonance Imaging MeSH
- Brain diagnostic imaging MeSH
- Prevalence MeSH
- Thrombectomy statistics & numerical data MeSH
- Thrombolytic Therapy statistics & numerical data MeSH
- Check Tag
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Geographicals
- Czech Republic MeSH
Stroke is one of the leading causes of mortality and the leading cause of functional impairment and cognitive deficits worldwide. It is important that clinical practice guidelines development is based on robust statistical and epidemiological data and their analysis throughout the whole process of guidelines development and implementation. The aim of this short communication is to analyse epidemiology of prevalence and incidence of ischaemic stroke, its main causes, brain imaging using MRI, recanalization therapies, secondary prevention with antiplatelet and anticoagulants, mortality data and to inform development of stroke clinical practice guidelines in the Czech Republic. The main analysed diagnosis was I63 (cerebral infarction) and secondary diagnoses were: I48 (atrial fibrillation and flutter), I35.9 (nonspecified aortic valve disease), Q21.1 (atrial septal defect) or I33.0 (acute and subacute endocarditis). We have also analysed use of brain imaging with MRI, recanalization treatment using intravenous thrombolysis and mechanical thrombectomy, stroke secondary prevention with antiplatelet drugs and anticoagulation as well as hospital admissions and mortality. In total, 159 344 patients were diagnosed with an ischaemic stroke from 2015 to 2017. Average prevalence of ischaemic stroke in the Czech Republic is 54.9 patients per 100 000. 22.2% of patients with stroke received intravenous thrombolysis or mechanical thrombectomy in 2017.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19044682
- 003
- CZ-PrNML
- 005
- 20200715143956.0
- 007
- ta
- 008
- 200109s2019 at f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1097/XEB.0000000000000189 $2 doi
- 035 __
- $a (PubMed)31283583
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a at
- 100 1_
- $a Líčeník, Radim $u Czech National Centre for Evidence-Based Healthcare and Knowledge Translation (Cochrane Czech Republic, Czech CEBHC JBI Centre of Excellence, Masaryk University GRADE Centre), Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
- 245 10
- $a Epidemiological analyses to inform stroke clinical practice guidelines development / $c R. Líčeník, J. Klugarová, A. Pokorná, M. Bezděková, J. Jarkovský, P. Búřilová, T. Nečas, J. Mužík, S. Šebestová, D. Dolanová, M. Hunčovský, L. Dušek, M. Klugar,
- 520 9_
- $a Stroke is one of the leading causes of mortality and the leading cause of functional impairment and cognitive deficits worldwide. It is important that clinical practice guidelines development is based on robust statistical and epidemiological data and their analysis throughout the whole process of guidelines development and implementation. The aim of this short communication is to analyse epidemiology of prevalence and incidence of ischaemic stroke, its main causes, brain imaging using MRI, recanalization therapies, secondary prevention with antiplatelet and anticoagulants, mortality data and to inform development of stroke clinical practice guidelines in the Czech Republic. The main analysed diagnosis was I63 (cerebral infarction) and secondary diagnoses were: I48 (atrial fibrillation and flutter), I35.9 (nonspecified aortic valve disease), Q21.1 (atrial septal defect) or I33.0 (acute and subacute endocarditis). We have also analysed use of brain imaging with MRI, recanalization treatment using intravenous thrombolysis and mechanical thrombectomy, stroke secondary prevention with antiplatelet drugs and anticoagulation as well as hospital admissions and mortality. In total, 159 344 patients were diagnosed with an ischaemic stroke from 2015 to 2017. Average prevalence of ischaemic stroke in the Czech Republic is 54.9 patients per 100 000. 22.2% of patients with stroke received intravenous thrombolysis or mechanical thrombectomy in 2017.
- 650 _2
- $a antikoagulancia $x aplikace a dávkování $7 D000925
- 650 _2
- $a mozek $x diagnostické zobrazování $7 D001921
- 650 _2
- $a ischemie mozku $x diagnostické zobrazování $x epidemiologie $x etiologie $x terapie $7 D002545
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a incidence $7 D015994
- 650 _2
- $a magnetická rezonanční tomografie $7 D008279
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a inhibitory agregace trombocytů $x aplikace a dávkování $7 D010975
- 650 _2
- $a prevalence $7 D015995
- 650 _2
- $a cévní mozková příhoda $x diagnostické zobrazování $x epidemiologie $x etiologie $x terapie $7 D020521
- 650 _2
- $a trombektomie $x statistika a číselné údaje $7 D017131
- 650 _2
- $a trombolytická terapie $x statistika a číselné údaje $7 D015912
- 651 _2
- $a Česká republika $x epidemiologie $7 D018153
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Klugarová, Jitka $u Czech National Centre for Evidence-Based Healthcare and Knowledge Translation (Cochrane Czech Republic, Czech CEBHC JBI Centre of Excellence, Masaryk University GRADE Centre), Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic. Institute of Health Information and Statistics, Prague, Czech Republic.
- 700 1_
- $a Pokorná, Andrea $u Czech National Centre for Evidence-Based Healthcare and Knowledge Translation (Cochrane Czech Republic, Czech CEBHC JBI Centre of Excellence, Masaryk University GRADE Centre), Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic. Department of Nursing, Faculty of Medicine, Masaryk University, Brno, Czech Republic. Institute of Health Information and Statistics, Prague, Czech Republic.
- 700 1_
- $a Bezděková, Monika $u Czech National Centre for Evidence-Based Healthcare and Knowledge Translation (Cochrane Czech Republic, Czech CEBHC JBI Centre of Excellence, Masaryk University GRADE Centre), Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic. Institute of Health Information and Statistics, Prague, Czech Republic.
- 700 1_
- $a Jarkovský, Jiří $u Czech National Centre for Evidence-Based Healthcare and Knowledge Translation (Cochrane Czech Republic, Czech CEBHC JBI Centre of Excellence, Masaryk University GRADE Centre), Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic. Institute of Health Information and Statistics, Prague, Czech Republic.
- 700 1_
- $a Búřilová, Petra $u Czech National Centre for Evidence-Based Healthcare and Knowledge Translation (Cochrane Czech Republic, Czech CEBHC JBI Centre of Excellence, Masaryk University GRADE Centre), Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic. Institute of Health Information and Statistics, Prague, Czech Republic. $7 xx0204142
- 700 1_
- $a Nečas, Tomáš $u Czech National Centre for Evidence-Based Healthcare and Knowledge Translation (Cochrane Czech Republic, Czech CEBHC JBI Centre of Excellence, Masaryk University GRADE Centre), Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Mužík, Jan $u Czech National Centre for Evidence-Based Healthcare and Knowledge Translation (Cochrane Czech Republic, Czech CEBHC JBI Centre of Excellence, Masaryk University GRADE Centre), Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic. Institute of Health Information and Statistics, Prague, Czech Republic.
- 700 1_
- $a Šebestová, Silvie $u Czech National Centre for Evidence-Based Healthcare and Knowledge Translation (Cochrane Czech Republic, Czech CEBHC JBI Centre of Excellence, Masaryk University GRADE Centre), Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic. Institute of Health Information and Statistics, Prague, Czech Republic.
- 700 1_
- $a Dolanová, Dana $u Czech National Centre for Evidence-Based Healthcare and Knowledge Translation (Cochrane Czech Republic, Czech CEBHC JBI Centre of Excellence, Masaryk University GRADE Centre), Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Hunčovský, Martin $u Czech National Centre for Evidence-Based Healthcare and Knowledge Translation (Cochrane Czech Republic, Czech CEBHC JBI Centre of Excellence, Masaryk University GRADE Centre), Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Dušek, Ladislav $u Czech National Centre for Evidence-Based Healthcare and Knowledge Translation (Cochrane Czech Republic, Czech CEBHC JBI Centre of Excellence, Masaryk University GRADE Centre), Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic. Institute of Health Information and Statistics, Prague, Czech Republic.
- 700 1_
- $a Klugar, Miloslav $u Czech National Centre for Evidence-Based Healthcare and Knowledge Translation (Cochrane Czech Republic, Czech CEBHC JBI Centre of Excellence, Masaryk University GRADE Centre), Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic. Institute of Health Information and Statistics, Prague, Czech Republic.
- 773 0_
- $w MED00176091 $t International journal of evidence-based healthcare $x 1744-1609 $g Roč. 17 Suppl 1, č. - (2019), s. S53-S56
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31283583 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200109 $b ABA008
- 991 __
- $a 20200715143953 $b ABA008
- 999 __
- $a ok $b bmc $g 1482951 $s 1083355
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 17 Suppl 1 $c - $d S53-S56 $e - $i 1744-1609 $m International journal of evidence-based healthcare $n Int J Evid Based Healthc $x MED00176091
- LZP __
- $a Pubmed-20200109